Skip to main content

Animations

MJFF Publications

351 - 360 of 8587 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2020
  • 2021
  • 2020
  • Summary Details
    RESTRICTED
    Title: LRRK2 signaling in neurodegeneration: two decades of progress
    Journal Name: Essays in Biochemistry
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1042/ebc20210013
    Best OA location URL:
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond
    Journal Name: Bioscience Reports
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bsr20203672
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia
    Journal Name: Seminars in Neurology
    Publisher: Georg Thieme Verlag KG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1055/s-0040-1715134
    Best OA location URL:
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Allosteric inhibition of LRRK2, where are we now
    Journal Name: Biochemical Society Transactions
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1042/bst20200424
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease
    Journal Name: Seminars in Thrombosis and Hemostasis
    Publisher: Georg Thieme Verlag KG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1055/s-0041-1733960
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: On demand therapy for Parkinson’s disease patients: Opportunities and choices
    Journal Name: Postgraduate Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/00325481.2021.1936087
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration
    Journal Name: Postgraduate Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/00325481.2020.1857992
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: A systematic review of group intervention for acquired dysarthria in adults
    Journal Name: Disability and Rehabilitation
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/09638288.2020.1859629
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Targeting mitophagy in Parkinson's disease
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.rev120.014294
    Citation Count: 72
  • Summary Details
    RESTRICTED
    Title: Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update
    Journal Name: Expert Opinion on Emerging Drugs
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14728214.2020.1763954
    Best OA location URL:
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.